Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gang Of One: Baucus Reminds Everyone Who's Boss With Health Bill Push

This article was originally published in The Pink Sheet Daily

Executive Summary

Senate Finance Committee chairman says legislation will be marked up the week of Sept. 21, reiterates the "door is open" for Republican support.

You may also be interested in...



Baucus Reform Framework Not So Taxing On Industry; $23 Billion Is Fee-Based

The collection of fees based on market share is expected to be less onerous for smaller companies than a tax based on sales.

Baucus Reform Framework Not So Taxing On Industry; $23 Billion Is Fee-Based

The collection of fees based on market share is expected to be less onerous for smaller companies than a tax based on sales.

Obama's Forthcoming Health Reform Speech Prompts Sen. Baucus To Cooperate

Senate Finance Committee proposal includes pharma excise tax, Medicare Commission, CER institute, and co-ops ­-- and leaves out public option, closing the donut hole and Part D rebates for dual eligibles.

Topics

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel